The problem of optimal reduction of blood pressure in hypertension treatment with autonomic drugs.
作者信息
SCHWALB H
出版信息
Med Klin. 1954 Oct 22;49(43):1723-7.
PMID:13223365
Abstract
摘要
相似文献
1
The problem of optimal reduction of blood pressure in hypertension treatment with autonomic drugs.
Med Klin. 1954 Oct 22;49(43):1723-7.
2
[The problem of considering kidney function in ganglion blocking therapy hypertension].[神经节阻断疗法治疗高血压时考虑肾功能的问题]
Dtsch Med Wochenschr. 1954 Sep 17;79(38):1409-11. doi: 10.1055/s-0028-1119872.
3
[Effects of a new ganglioplegic derivative of methylpyrrolidine, Sy 108, on arterial pressure].[甲基吡咯烷新型神经节阻断衍生物Sy 108对动脉血压的影响]
Schweiz Med Wochenschr. 1956 Feb 18;86(7):172-4.
4
A new orally active quaternary ammonium, ganglion blocking drug capable of reducing blood pressure, Su-3088.一种新型口服活性季铵类神经节阻断药物，能够降低血压，苏-3088。
Circulation. 1955 May;11(5):733-41. doi: 10.1161/01.cir.11.5.733.
5
6
[Studies of the effect of serpasil and ecolid on blood circulation in arterial hypertension].
Cardiologia (Basel). 1957;31(1):51-78.
7
[Renal function of hypertensive patients treated with ganglion-blocking agents].[用神经节阻断剂治疗的高血压患者的肾功能]
G Ital Chir. 1957 Dec;13(12):1281-8.
8
Hypotensive actions of hexamethonium bromide and some of its homologues; their use in high blood-pressure.溴化六甲铵及其某些同系物的降压作用；它们在高血压治疗中的应用。
Lancet. 1952 Nov 22;2(6743):1002-5. doi: 10.1016/s0140-6736(52)91181-1.
9
[New drugs for therapy of hypertension].
Med Klin. 1954 May 14;49(20):801-4.
10
[Treatment of essential hypertension with hypotensive drugs].
Tidsskr Nor Laegeforen. 1958 Jul 1;78(13-14):638-41 passim.
Zotero 插件